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BACKGROUND AND OBJECTIVE: Lipoid congenital adrenal hyperplasia (LCAH) is the most 
severe form of adrenal hyperplasia and mutations in the StAR gene are the most common cause of 
the disease. Adrenal insufficiency and cholestasis are reported in few patients. The aim of this study 
was to report the results of treatment of two sisters with lipoid CAH and cholestatic jaundice. CASE 
REPORTS: Here, we present two sisters at the age of 30 and 60 days with conjugated 
hyperbilirubinemia and elevated liver enzymes and adrenal insufficiency. They had a 46,XY 
karyotype with external female genitalia without uterus and ovaries. LCAH was detected through 
electrolyte abnormalities, increased ACTH, decreased levels of cortisol and sex hormones and was 
confirmed by determination of exome sequencing and Sanger sequencing. In these patients, a 
homozygous mutation (c.653C>T) in exon 6 of STAR gene was identified. The patients were 
treated with 10 mg of hydrocortisone IV every 8 hours for 3 days; oral hydrocortisone was then 
administered at a dose of 2.5 mg every 8 hours and 0.2 mg fludrocortisone daily. One month after 
the therapy, levels of bilirubin and liver enzymes of these patients became normal. The first patient 
died 7 months after her mother stopped giving the drugs to the child. The other patient is now 9 
years old. She is in good clinical condition as her treatment goes on. CONCLUSION: Considering 
the reported cases, adrenal lipoid hyperplasia should be considered as a rare cause of cholestasis 
with adrenal insufficiency in patients. © 2021, Babol University of Medical Sciences. All rights 
reserved. 
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